News

Bank of America Securities Sticks to Their Buy Rating for Day One Biopharmaceuticals (DAWN)
In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Day One Biopharmaceuticals (DAWN – ...
Bank of America Securities Sticks to Its Buy Rating for Neurocrine (NBIX)
In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Neurocrine (NBIX – Research Report), with a ...
What's Going On With Bank Of America (BAC) Shares
Bank of America shares are trading higher by 4.1% since Monday's open. The company this week reported stronger-than-expected ...